Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment-Reference-Cited by-同舟云学术

Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment

Published:2007-03-13 Issue:6 Volume:7 Page:418-426
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Molero P,Ortuño F,Zalacain M,Patiño-García A

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/6500441.pdf

Reference41 articles.

1. McGuffin P, Owen MJ, Farmer AE . Genetics basis of schizophrenia. Lancet 1995; 346: 678–682.

2. Sullivan PF, Kendler KS, Neale MC . Schizophrenia as a complex trait – evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187–1192.

3. Badner JA, Gershon ES . Meta-analysis of whole-genome linkage scans of bipolar disorder and schizofrenia. Mol Psychiatry 2002; 7: 405–411.

4. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003; 73: 34–48.

5. Murphy KC . Schizophrenia and velo-cardial-facial syndrome. Lancet 2002; 359: 426–430.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy;Biomolecules;2024-06-29

2. Pharmacogenomic screening for agranulocytosis and efficacy with clozapine;Journal of Translational Genetics and Genomics;2023

3. The inconsistent mediating effect of catechol O methyl transferase Val158Met polymorphism on the sex difference of cognitive impairment in schizophrenia patients;Frontiers in Psychiatry;2022-09-20

4. The effects of catechol‐O‐methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: A systematic review and meta‐analysis;PsyCh Journal;2022-05-31

5. Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: An Updated Meta-Analysis;Current Neuropharmacology;2021-10-18